Servet KARAGÜL, Oktay KARAKOSE, Kazim Çaglar OZCELİK

Surgical technique and short-term outcomes in esophageal squamous cell carcinoma : A single center experience

Aim: Esophagus cancers are the 8th most commonly seen cancers worldwide and the 6th cause of cancer-related mortality. Bythe time they are diagnosed they are generally not resectable and therefore have a poor prognosis. This is a complex diseasethat requires a multi-disciplinary approach. Apart from early stage tumors, surgery is recommended following chemoradiotherapy.Squamous cell carcinomas are seen more frequently and several surgical methods are applied for curative resection. The aim of thisstudy was to present the surgical techniques applied to patients who underwent surgery for esophagus squamous cell carcinomaand to discuss the postoperative outcomes.Material and Methods: A retrospective review was made of the records of 14 patients with esophagus squamous cell carcinomawho underwent surgery in Samsun Training and Research Hospital between June 2016 and September 2018. Patients’ demographicdata, diagnoses, tumor characteristics, postoperative complications, mortality, and clinical findings during follow-up were recorded.Results: The study included 14 patients, comprising 9 females and 5 males with a median age was 65.3 years (range, 39-80 years).Transhiatal esophagectomy was applied to 12 patients and thoraco-laparoscopic (TL) esophagectomy to 2 patients. No intraoperativecomplications developed in the patients applied with TL esophagectomy. In 3 of the patients applied with transhiatalesophagectomy, pneumothorax developed. No early or late postoperative complications developed in the patients applied with TLesophagectomy. In the transhiatal esophagectomy group, anastomosis leakage was observed in 2 patients and wound site infectionin 1. The median length of hospital stay was 14 days (range, 7-39 days), and median postoperative follow-up was 12.5 months(range, 4-22 months).Conclusion: Despite small number of patients and short follow up, our study suggest that surgery-related morbidity and mortalitywill be lower in minimally invasive esophagectomy.

PDF

___

1. Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev 2011;12:2461-6.
2. Matejcic M, Li D, Prescott NJ, Prescott NJ, et al. Association of a deletion of GSTT2B with an altered risk of oesophageal squamous cell carcinoma in a South African population: a case-control study. PLoS One 2011;6:29366.
3. Ürün Y, Akbulut H. Induction and adjuvant treatment of esophageal cancer. Toraks Cerrahisi Bülteni 2013 4:47-52.
4. Gebski V, Burmeister B, Smithers BM, et al: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226-34.
5. Ajani JA, D’Amico TA, Bentrem DJ et al. Esophageal and Esophagogastric Junction Cancers in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines version 2.2019). https://www.nccn.org/professionals/physician_ gls/pdf/esophageal.pdf.
6. Toktaş O, İliklerden Ü, Yerlikaya B, et al. Thoracoscopic- Laparoscopic Esophagectomy for Carcinoma of the Esophagus: Preliminary Reports of Seven Cases from the High-volume Institution. Van Tıp Derg 2016;23:40-5.
7. Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008;85:424-9.
8. Rice TW, Kelsen D, Blackstone EH, et al. Esophagus and esophagogastric junction. In: Amin MB, Edge S, Greene F, et al, eds. AJCC Cancer Staging Manual 8th ed New York: Springer; 2017:185-202.
9. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
10. Shapiro J, van Lanschot JJ, Hulshof MC, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial. Lancet Oncol 2015;16:1090–8.
11. van Hagen P, Hulshof MC, van Lanschot JJ et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366:2074–84.
12. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated metaanalysis. Lancet Oncol 2011;12:681–92.
13. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital Volume And Surgical Mortality İn The United States. N Engl J Med 2002;346:1128-37.
14. Mawhinney MR, Glasgow RE. Current treatment options for the management of esophageal cancer. Cancer Manag Res. 2012;4:367–77
15. Visbal AL, Allen MS, Miller DL, et al. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 2001;71:1803-8.
16. McKeown KC. Total three-stage oesophagectomy for cancer of the oesophagus. Br J Surg 1976;63:259-62.
17. Birkmeyer JD, Dimick JB, Staiger DO. Operative mortality and procedure volume as predictors of subsequent hospital performance. Ann Surg 2006;243:411-7.
18. Law S, Wong KH, Kwok KF, et al.Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004 Nov;240(5):791- 800.
19. Hulscher JBF, van Sandick JW, de Bor AGEM, et al. Extended transthoracic resection compared whit limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
20. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003;238:486-94.
21. Palanivelu C, Prakash A, Senthilkumar R, et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position experience of 130 patients. J Am Coll Surg 2006;203:7-16.
22. Noshiro H, Iwasaki H, Kobayashi K, et al. Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer. Surg Endosc 2010;24:2965-73.
23. Godiris-Petit G, Munoz-Bongrand N, Honigman I, et al. Minimally invasive esophagectomy for cancer: prospective evaluation of laparoscopic gastric mobilization. World J Surg 2006;30:1434-40.
24. Taurchini M, Cuttitta A. Minimally invasive and robotic esophagectomy: state of the art. J Vis Surg 2017;3:125.